Deacetylation of cinobufagin by rat liver.
The enzyme system mediating the deacetylation of cinobufagin (CB) at the 16-position to give deacetylCB was characterized in the rat. Tissue distribution studies showed that the highest activity of CB deacetylation was mainly localized in the liver microsomal fraction. Some activity was also detected in the serum and intestine. Kinetic studies of the enzymatic reaction carried out by microsomes demonstrated that the formation of deacetyl-CB increased linearly with time up to 60 min and with protein content up to 10 mg. Apparent Km and Vmax values calculated from Lineweaver-Burk plots were 2.7 x 10(-4) M and 4.17 nmol/mg of protein/min, respectively. Low concentrations of several metal salts (AgNO3, MgCl2, CoSO4, and CuCl2) did not affect CB deacetylase activity. Microsomal CB deacetylation was inhibited by the organophosphorus compounds cyanox and fenitrothion at 1.0 x 10(-6) M. Eserine sulfate, disulfiram, rifampicin, and phenacetin at 1.0 x 10(-4) M also decreased CB deacetylase activity. Aspirin, sodium fluoride, and EDTA at 1.0 x 10(-3) M did not inhibit the deacetylation. In vivo treatment of rats with phenobarbital resulted in a 2-fold increase in microsomal CB deacetylase activity. All of these results suggest that the enzyme responsible for CB deacetylation is somewhat different from the other characterized esterases.
Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan.
L
L
Zhang
K
K
Aoki
T
T
Yoshida
Y
Y
Kuroiwa
D000107:Acetylation / Q000187:drug effects; D000581:Amidohydrolases / Q000378:metabolism*; D000818:Animals; D002018:Bufanolides / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D004355:Drug Stability; D004365:Drugs, Chinese Herbal / Q000378:metabolism*; D004795:Enzyme Stability; D004950:Esterases / Q000037:antagonists & inhibitors; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D009928:Organ Specificity; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution
D002018:Bufanolides; D004365:Drugs, Chinese Herbal; D004950:Esterases; D000581:Amidohydrolases; C002471:cinobufagin; D010634:Phenobarbital